Analysis of the Real-world Prescription Pattern of Palbociclib Combination Therapy With Aromatase Inhibitor as a First Line Therapy in Metastatic Breast Cancer Patients Using the National Health Insurance Claims Data in South Korea
Clinical trial NCT05132101 · COMPLETED
Trial details
- NCT number
- NCT05132101
- Sponsor
- Pfizer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-12-20
- Primary completion
- 2022-03-14
- Enrollment
- 2758
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.